Author

Gerrit Borchard

University of GenevaORCID 0000-0001-6268-2586Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Cindy Schelker· 2 shared Patrycja M. Nowak-SliwinskaiD· 2 shared Catia Monteiro· 1 shared Victoria Trap· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

4 top collaborators · 5 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Cindy Schelker

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 8, 2025

Co-encapsulated liposomal formulations of tubacin and erlotinib.HCl: a comprehensive stability strategy

Cindy Schelker, Catia Monteiro, Gerrit Borchard, Patrycja M. Nowak-Sliwinska

This study develops a stable liposomal formulation of tubacin and erlotinib.HCl using freeze-drying and cryoprotectants to maintain drug encapsulation and particle size.

DOI 10.1101/2025.10.08.681158

experimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 6, 2025

Development of a liposomal formulation of a TKI: the active loading of erlotinib.HCl

Cindy Schelker, Victoria Trap, Gerrit Borchard, Patrycja M. Nowak-Sliwinska

This study develops a liposomal formulation of erlotinib.HCl, demonstrating successful active loading and highlighting differences in toxicity and uptake between 2D cell lines and patient-derived organoids.

DOI 10.1101/2025.06.06.658400

humanexperimental assay

𝕏 PostBluesky